Introducing LEDGER FLEX — Easy, Secure Self-Custody, Free From Compromise
Ledger, the world leader in Digital Asset security for consumers and enterprises, today launched for sale Ledger Flex, its second new product launch in 2024. Released during Ledger’s tenth anniversary, Ledger Flex and the previously released Ledger Stax mark the inception of a new generation of Ledger hardware, featuring secure E Ink® touchscreen displays powered by Ledger’s Secure OS. Ledger Flex is available to purchase today on Ledger.com and through our retail partners around the world for $249, shipping immediately.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726882083/en/
Ledger Flex™ (Photo: Business Wire)
Ledger Flex marks the new standard for Ledger devices, featuring NFC and a secure E Ink® touchscreen, at an attractive price point. Ledger Flex is an homage to the iconic black and steel motif featured on Ledger devices for a decade, a reminder of Ledger’s heritage of uncompromising security. Its high-resolution, 2.8” display provides clarity when signing transactions or approving logins. E Ink® offers unmatched energy efficiency, so the battery can last for weeks or even months on one charge.
“After a decade of setting the standard for security and self-custody in crypto and digital assets, I’m proud to say we’re raising the bar again,” says Pascal Gauthier, Chairman & CEO of Ledger. “By launching both Ledger Flex and Ledger Stax this year, we’re redefining the experience of self-custody. Ledger devices already secure more than 20% of the world’s digital assets, and our new secure touchscreen category will make self-custody more accessible than ever before for more consumers and enterprises.”
Secure signing devices are key to a future where Proof of You becomes essential — as more of our value becomes digitized, society will need trusted methods to prove identity. The rapid advancement of AI pushes provenance to the forefront of technology’s biggest challenges, and trusting what you see becomes increasingly difficult. Ledger devices are the only products in the world with secure touchscreens, making them essential for protecting both your digital value and your identity. Ledger devices bring security to your inherently insecure devices.
After a decade of building uncompromising secure devices and a robust open-source developer ecosystem, Ledger is ready to secure a world that’s embracing AI. Where AI creates abundance, the blockchain is a natural partner by creating scarcity and authenticity. Ledger secures the blockchain, and will build applications to serve the need for Proof of You.
This begins with a new app for Ledger Stax and Ledger Flex: Ledger Security Key, providing Two-Factor Authentication (2FA) and Passkey capabilities. Passkeys provide a secure and convenient alternative to traditional passwords, and can eliminate phishing from your security risk factors. With Ledger Security Key, you can use your Ledger wallet to login without having to pull up your password or use a less secure 2FA such as a browser extension or SMS. This feature is built on the open FIDO 2 specification, ensuring decentralized access across platforms, and is already compatible with Google, Amazon, Binance, Coinbase, and much more. Simply tap your Ledger Flex or Ledger Stax to your phone to login to supported services, or connect via USB to your laptop or PC.
“Without a secure screen, you are not secure. Period. The easy-to-use secure touchscreens of Ledger Stax and Ledger Flex are the only truly secure touchscreens in the world, battle tested by the Donjon and third parties,” says Ian Rogers, Chief Experience Officer at Ledger. “With growing digital ownership and AI fakes, digital asset security, proof-of-humanity, and proof-of identity is more crucial than ever. Ledger Stax and Ledger Flex are the secure touchscreens to go with the insecure touchscreen in your pocket.”
Ledger Flex is partnered by Ledger Live, the leading omni-chain companion app, which enables users to connect seamlessly with their Ledger device. Ledger Live is the most secure way to buy, sell, swap and earn yield on your crypto, integrated with global providers such as Moonpay, Coinbase, PayPal, and Lido. To date, Ledger supports over 10,000 coins & tokens on more than 70 blockchains in Ledger Live, and approximately 200 dApps have been integrated into the Ledger ecosystem. Developers who want to build on the Ledger ecosystem can check out our updated Developer Portal here.
Embracing a future built on digital value requires secure recovery options, ensuring your digital value or identity is never lost. In 2023 Ledger launched Ledger Recover, provided by Coincover, a service that enables users to encrypt, shard, and backup their secret recovery phrase, which supports Ledger Flex from launch, in addition to the already available Ledger Stax. With Ledger Recover you never have to worry about recovering access to your wallet, even if your physical Secret Recovery Phrase backup is lost or destroyed. With Ledger Live, ™Ledger Security Key, and Ledger Recover, the entire digital ownership experience is present and possible only on the Ledger ecosystem.
Ledger Flex is available today on Ledger.com and in Best Buy all across the US for $249. A special Ledger Flex BTC Edition is also available. Accessories to protect your Ledger Stax and Ledger Flex are shipping now.
With the introduction of Ledger Flex, there is now a Ledger device available at a price point for everyone:
LEDGER NANO S PLUS™: Ledger’s uncompromising security for your Bitcoin and crypto, available for just $79.
LEDGER NANO X™: More connectivity, featuring Bluetooth for on the go transactions at $149.
LEDGER FLEX™: Ledger’s next-generation touch interface and form factor at $249.
LEDGER STAX™: Premium next-gen design featuring the world’s first curved E Ink® display, with Qi charging and stacking magnets. Designed by Tony Fadell. Secured by Ledger, at $399, with a magnet shell in every box.
LEDGER FLEX SPECS:
Dimensions: 78.40 mm × 56.50 mm × 7.70 mm
Security: Ledger EAL 6+ certified secure element (ST33K1M5)
Screen type: E Ink® (up to 16 grays), customizable always-on lock screen, capacitive touch
Screen resolution: 2.8”, 600 x 480 pixels
Weight: 57.5g
Connectivity: USB C, Bluetooth® 5.2, NFC
ABOUT LEDGER
Celebrating its 10 year anniversary in 2024, Ledger is the world leader in Digital Asset security for consumers and enterprises. Ledger offers connected devices and platforms, with more than 6M devices sold to consumers in 180 countries and 10+ languages, 100+ financial institutions and commercial brands. Over 20% of the world’s crypto assets are secured by Ledger.
Ledger is the digital asset solution secure by design. The world’s most internationally respected offensive security team, Ledger Donjon, is relied upon as a crucial resource for securing the world of Digital Assets. With over 14 billion dollars hacked, scammed or mismanaged in 2023 alone, Ledger’s security brings peace of mind and uncompromising self-custody to its community.
Don’t buy “a hardware wallet.” Buy a LEDGER™ device.
LEDGER™, LEDGER LIVE™, LEDGER RECOVER™, LEDGER STAX™, LEDGER FLEX™ and LEDGER FREE FROM COMPROMISE™ are trademarks owned by Ledger SAS
Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Ledger is under license.
E Ink® is a registered trademark of E Ink Corporation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240726882083/en/
Contacts
Seamus Conwell
seamus.conwell@150bond.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press Release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press Release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press Release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press Release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom